22 . July , 2018 - Sunday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Labetalol HCl

Big Image Pronouncation: (la-BET-uh-lahl HIGH-droe-KLOR-ide)
Class: Alpha-adrenergic blocker, Beta-adrenergic blocker

Trade Names:
Trandate
- Tablets 100 mg
- Tablets 200 mg
- Tablets 300 mg
- Injection 5 mg/mL

Apo-Labetalol (Canada)

Mechanism of Action

Pharmacology

Selectively blocks alpha-1 receptors and nonselectively blocks beta-receptors to decrease BP, heart rate, and myocardial oxygen demand.

Pharmacokinetics

Absorption

Completely absorbed from the GI tract. T max is 1 to 2 h. Relative bioavailability is 100% (oral and solution). Absolute bioavailability for oral compared with IV is 25%. Absolute bioavailability increases when administered with food. Steady-state levels are reached by about the third day of dosing.

Distribution

Crosses the placental barrier. Approximately 50% protein bound.

Metabolism

Mainly though conjugation to glucuronide metabolites.

Elimination

Plasma t ½ is 6 to 8 h (not altered in patient with decreased hepatic or renal function). Metabolites excreted in urine and via the bile into the feces. Approximately 55% to 60% appears in urine as conjugates or unchanged labetalol within 24 h. Neither hemodialysis nor peritoneal dialysis removes a significant amount of labetalol from the general circulation.

Peak

2 to 4 h.

Duration

Lasting at least 8 h following single oral dose of 100 mg and more than 12 h after a 300 mg dose.

Special Populations

Elderly

Elimination is reduced; lower maintenance dosage is generally required in elderly.

Indications and Usage

Management of hypertension.

Unlabeled Uses

Treatment of pheochromocytoma; management of clonidine-withdrawal hypertension.

Contraindications

Severe bradycardia; second- and third-degree heart block; heart failure; cardiogenic shock; bronchial asthma.

Dosage and Administration

Adults

PO 100 mg twice daily initially; maintenance dose usually 200 to 400 mg twice daily. IV 20 mg over 2 min; then 40 to 80 mg every 10 min up to max of 300 mg. Infusions of 2 mg/min can be initiated and titrated to response.

General Advice

  • Tablets
  • Administer with food; tablets can be crushed.
  • If nausea and dizziness occur with twice-daily dosing of oral form, same total daily dose can be administered as divided doses 3 times/day.
  • Injection
  • Keep patient supine during IV administration and for 3 h afterward.
  • Labetalol is compatible with following parenteral solutions: Ringer's, Lactated Ringer's, dextrose 5% and Ringer's, Lactated Ringer's 5% and dextrose 5%, dextrose 5%, sodium chloride 0.9%, dextrose 5% and sodium chloride 0.2%, dextrose 2.5% and sodium chloride 0.45%, dextrose 5% and sodium chloride 0.9%, and dextrose 5% and sodium chloride 0.33%.
  • Do not freeze injection vials. Protect from light. Parenteral solution is stable for 24 h after dilution.

Storage/Stability

Tablets

Store at controlled temperature (59° to 86°F).

Injection

Store injection in refrigerator at controlled room temperature (59° to 86°F). Protect from light. Parenteral solution is stable for 24 h after dilution.

Drug Interactions

Beta-adrenergic agonists

Blunted bronchodilator effect.

Cimetidine

Increased bioavailability of labetalol.

Indomethacin

Impaired antihypertensive effect of labetalol.

Inhalation anesthetics

May exaggerate hypotension.

Nitroglycerin

Increased hypotension.

Incompatibility

Injection not compatible with sodium bicarbonate 5%.

Laboratory Test Interactions

Drug may cause false-positive increases in levels of urinary catecholamines.

Adverse Reactions

Cardiovascular

Orthostatic hypotension; edema; flushing; ventricular arrhythmias; AV block; bradycardia; heart failure; chest pain.

CNS

Headache; fatigue; dizziness; depression; lethargy; drowsiness; forgetfulness; sleepiness; vertigo; paresthesia; nightmares.

Dermatologic

Tingling of scalp; rash; facial erythema; alopecia; urticaria; pruritus; increased sweating.

EENT

Dry eyes; visual disturbances; altered taste perception.

GI

Nausea; vomiting; diarrhea; dyspepsia.

Genitourinary

Impotence; urinary retention; difficulty with urination; failure to ejaculate; priapism; Peyronie disease.

Hematologic

Leukopenia.

Hepatic

Elevated transaminases; jaundice; cholestasis.

Metabolic

Increases or decreases in serum glucose; increased creatinine and BUN.

Respiratory

Bronchospasm; shortness of breath; wheezing.

Miscellaneous

Muscle cramps; systemic lupus erythematosus; increased hypoglycemic response to insulin; masking of hypoglycemic signs; asthenia.

Precautions

Pregnancy

Category C .

Lactation

Excreted in breast milk.

Children

Safety and efficacy not established.

Special Risk Patients

Use with caution in patients with diabetes mellitus, CHF, respiratory difficulties, or severely elevated BP.

Cardiac failure

Cardiac failure has been observed in patients with or without history.

Withdrawal

Do not discontinue abruptly. Abrupt discontinuation may worsen angina and precipitate ischemic event in susceptible individuals.

Overdosage

Symptoms

Excessive orthostatic hypotension, excessive bradycardia, cardiac failure, bronchospasm, seizures.

Patient Information

  • Caution patient to avoid sudden position changes to prevent orthostatic hypotension. Advise use of support hose.
  • Advise patient to notify dentist and other health care providers of drug therapy before treatment or surgery.
  • Caution diabetic patient to monitor serum glucose carefully.
  • Instruct patient to not discontinue drug abruptly.
  • Advise patient to carry medical identification (eg, card, bracelet) indicating medical condition and drug regimen.
  • Instruct patient how to measure BP and pulse.
  • Emphasize importance of the following other modalities on BP: weight control, regular exercise, smoking cessation and moderate intake of alcohol and salt.
  • Inform patient that transient scalp tingling may occur, especially when treatment is initiated.
  • Instruct patient to report the following symptoms to health care provider: slow heart rate, dizziness, confusion, fever or depression, shortness of breath, fatigue, swelling of ankles and feet.
  • Advise patient that drug causes dizziness and to use caution while driving or performing other tasks requiring mental alertness.

Recent Drug Updates at DrugIndexOnline:





Clioquinol Clioquinol
Some commonly used brand names are: In Canada— Vioform Another commonly used name is iodochlorhydroxyquin . * Not commercially available in the U.S. Category Antibacterial, topical Antifungal, topical Description Clioquinol (klye-oh-KWIN-ole) belongs to the family of medicines ca more...

Exforge Exforge
Generic Name: amlodipine and valsartan (am LOE de peen val SAR tan) Brand Names: Exforge What is amlodipine and valsartan? Amlodipine is in a group of drugs called calcium channel blockers. It works by relaxing the muscles of your heart and blood vessels. Amlodipine and valsartan is in a more...

Fexofenadine/Pseudoephedrine Extended-Release Tablets (12 Hour) Fexofenadine/Pseudoephedrine Extended-Release Tablets (12 Hour)
Generic Name: Fexofenadine/Pseudoephedrine Extended-Release Tablets (12 Hour) (FEX-oh-FEN-a-deen/SOO-doe-e-FED-rin) Brand Name: Allegra-DFexofenadine/Pseudoephedrine Extended-Release Tablets (12 Hour) is used for:Relieving seasonal allergy symptoms, including sneezing, runny nose, itchy nose/pal more...

Gastrografin Gastrografin
Generic Name: diatrizoate meglumine and diatrizoate sodium Dosage Form: Solution Gastrografin Description Gastrografin (Diatrizoate Meglumine and Diatrizoate Sodium Solution) is a palatable lemon-flavored water-soluble iodinated radiopaque contrast medium for oral or rectal administration only. E more...

Humulin 40/60 Humulin 40/60
Some commonly used brand names are: In the U.S.— Humulin 50/50 14 Humulin 70/30 14 Humulin 70/30 Pen 14 Humulin L 10 Humulin N 13 Humulin N Pen 13 Humulin R 7 Humulin R, Regular U-500 (Concentrated) 7 Humulin U 5 Lente Iletin II 8 Lente 8 Novolin 70/30 14 Novolin L 10 Novolin N 13 Novolin more...

Miglustat Miglustat
Generic Name: Miglustat (mih-GLUE-stat) Brand Name: ZavescaMiglustat is used for:Treating mild to moderate type I Gaucher disease in patients for whom enzyme replacement therapy is not appropriate. Miglustat is a glucosylceramide synthase inhibitor. It works by blocking an enzyme that reduces more...

Naphcon Forte Naphcon Forte
Generic Name: naphazoline ophthalmic (na FAZ oh leen) Brand Names: AK-Con, Albalon, Allerest Eye Drops, Clear Eyes, Degest 2, Estivin II, Nafazair, Naphcon, Naphcon Forte, VasoClear, Vasocon What is Naphcon Forte (naphazoline ophthalmic)? Naphazoline ophthalmic causes constriction of bl more...

Neo-Synephrine 12 Hour Spray Nasal Neo-Synephrine 12 Hour Spray Nasal
Some commonly used brand names are: In the U.S.— Afrin Cherry 12 Hour Nasal Spray Afrin Extra Moisturizing 12 Hour Nasal Spray Afrin Original 12 Hour Nasal Spray Afrin Original 12 Hour Nose Drops Afrin Sinus 12 Hour Nasal Spray Afrin Original 12 Hour Pump Mist Dristan 12-Hr Nasal Spray Du more...